Genocea Biosciences
GNCA
#11015
Rank
โ‚ฌ0 M
Marketcap
0,00008780ย โ‚ฌ
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)

EPS for Genocea Biosciences (GNCA)

EPS in 2022 (TTM): -0,46ย โ‚ฌ

According to Genocea Biosciences 's latest financial reports the company's current EPS (TTM) is -0,46ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -0,42ย โ‚ฌ an increase over its 2020 EPS that were of -1,02ย โ‚ฌ.

EPS history for Genocea Biosciences from 2014 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-0,46ย โ‚ฌ9.21%
2021-0,42ย โ‚ฌ-58.62%
2020-1,02ย โ‚ฌ-48.21%
2019-1,97ย โ‚ฌ
2017-13,91ย โ‚ฌ13.14%
2016-12,29ย โ‚ฌ-3.31%
2015-12,71ย โ‚ฌ-23.31%
2014-16,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,15ย โ‚ฌ-351.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,12ย โ‚ฌ-784.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
2,41ย โ‚ฌ-626.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-2,73ย โ‚ฌ 498.08%๐Ÿ‡บ๐Ÿ‡ธ USA
iBio
IBIO
-1,35ย โ‚ฌ 196.15%๐Ÿ‡บ๐Ÿ‡ธ USA